Global Bispecific Antibody Molecular Drug Market Growth 2022-2028
The global market for Bispecific Antibody Molecular Drug is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Bispecific Antibody Molecular Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Bispecific Antibody Molecular Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Bispecific Antibody Molecular Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Bispecific Antibody Molecular Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Bispecific Antibody Molecular Drug players cover MacroGenics, Xencor, Medimmune, Merrimsck and Merus NV, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Bispecific Antibody Molecular Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Bispecific Antibody Molecular Drug market, with both quantitative and qualitative data, to help readers understand how the Bispecific Antibody Molecular Drug market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Bispecific Antibody Molecular Drug market and forecasts the market size by Type (EGFR×HER3 Target, PD-1×CTLA-4 Target and HER2×HER3 Target), by Application (Pancreatic Cancer, Breast Cancer, Colorectal Cancer and Non-Small Cell Lung Cancer), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
EGFR×HER3 Target
PD-1×CTLA-4 Target
HER2×HER3 Target
Segmentation by application
Pancreatic Cancer
Breast Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Solid Tumor
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
MacroGenics
Xencor
Medimmune
Merrimsck
Merus NV
Genentech
Zhongshan Kangfang Biology Medicine
Sichuan Baili Pharmaceutical
Alphamab Oncology
Chapter Introduction
Chapter 1: Scope of Bispecific Antibody Molecular Drug, Research Methodology, etc.
Chapter 2: Executive Summary, global Bispecific Antibody Molecular Drug market size (sales and revenue) and CAGR, Bispecific Antibody Molecular Drug market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Bispecific Antibody Molecular Drug sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Bispecific Antibody Molecular Drug sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Bispecific Antibody Molecular Drug market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including MacroGenics, Xencor, Medimmune, Merrimsck, Merus NV, Genentech, Zhongshan Kangfang Biology Medicine, Sichuan Baili Pharmaceutical and Alphamab Oncology, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bispecific Antibody Molecular Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Bispecific Antibody Molecular Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Bispecific Antibody Molecular Drug by Country/Region, 2017, 2022 & 2028
2.2 Bispecific Antibody Molecular Drug Segment by Type
2.2.1 EGFR×HER3 Target
2.2.2 PD-1×CTLA-4 Target
2.2.3 HER2×HER3 Target
2.3 Bispecific Antibody Molecular Drug Sales by Type
2.3.1 Global Bispecific Antibody Molecular Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Bispecific Antibody Molecular Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Bispecific Antibody Molecular Drug Sale Price by Type (2017-2022)
2.4 Bispecific Antibody Molecular Drug Segment by Application
2.4.1 Pancreatic Cancer
2.4.2 Breast Cancer
2.4.3 Colorectal Cancer
2.4.4 Non-Small Cell Lung Cancer
2.4.5 Solid Tumor
2.4.6 Others
2.5 Bispecific Antibody Molecular Drug Sales by Application
2.5.1 Global Bispecific Antibody Molecular Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Bispecific Antibody Molecular Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Bispecific Antibody Molecular Drug Sale Price by Application (2017-2022)
3 Global Bispecific Antibody Molecular Drug by Company
3.1 Global Bispecific Antibody Molecular Drug Breakdown Data by Company
3.1.1 Global Bispecific Antibody Molecular Drug Annual Sales by Company (2020-2022)
3.1.2 Global Bispecific Antibody Molecular Drug Sales Market Share by Company (2020-2022)
3.2 Global Bispecific Antibody Molecular Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Bispecific Antibody Molecular Drug Revenue by Company (2020-2022)
3.2.2 Global Bispecific Antibody Molecular Drug Revenue Market Share by Company (2020-2022)
3.3 Global Bispecific Antibody Molecular Drug Sale Price by Company
3.4 Key Manufacturers Bispecific Antibody Molecular Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bispecific Antibody Molecular Drug Product Location Distribution
3.4.2 Players Bispecific Antibody Molecular Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Bispecific Antibody Molecular Drug by Geographic Region
4.1 World Historic Bispecific Antibody Molecular Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Bispecific Antibody Molecular Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Bispecific Antibody Molecular Drug Annual Revenue by Geographic Region
4.2 World Historic Bispecific Antibody Molecular Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Bispecific Antibody Molecular Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Bispecific Antibody Molecular Drug Annual Revenue by Country/Region
4.3 Americas Bispecific Antibody Molecular Drug Sales Growth
4.4 APAC Bispecific Antibody Molecular Drug Sales Growth
4.5 Europe Bispecific Antibody Molecular Drug Sales Growth
4.6 Middle East & Africa Bispecific Antibody Molecular Drug Sales Growth
5 Americas
5.1 Americas Bispecific Antibody Molecular Drug Sales by Country
5.1.1 Americas Bispecific Antibody Molecular Drug Sales by Country (2017-2022)
5.1.2 Americas Bispecific Antibody Molecular Drug Revenue by Country (2017-2022)
5.2 Americas Bispecific Antibody Molecular Drug Sales by Type
5.3 Americas Bispecific Antibody Molecular Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bispecific Antibody Molecular Drug Sales by Region
6.1.1 APAC Bispecific Antibody Molecular Drug Sales by Region (2017-2022)
6.1.2 APAC Bispecific Antibody Molecular Drug Revenue by Region (2017-2022)
6.2 APAC Bispecific Antibody Molecular Drug Sales by Type
6.3 APAC Bispecific Antibody Molecular Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bispecific Antibody Molecular Drug by Country
7.1.1 Europe Bispecific Antibody Molecular Drug Sales by Country (2017-2022)
7.1.2 Europe Bispecific Antibody Molecular Drug Revenue by Country (2017-2022)
7.2 Europe Bispecific Antibody Molecular Drug Sales by Type
7.3 Europe Bispecific Antibody Molecular Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bispecific Antibody Molecular Drug by Country
8.1.1 Middle East & Africa Bispecific Antibody Molecular Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Bispecific Antibody Molecular Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Bispecific Antibody Molecular Drug Sales by Type
8.3 Middle East & Africa Bispecific Antibody Molecular Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bispecific Antibody Molecular Drug
10.3 Manufacturing Process Analysis of Bispecific Antibody Molecular Drug
10.4 Industry Chain Structure of Bispecific Antibody Molecular Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bispecific Antibody Molecular Drug Distributors
11.3 Bispecific Antibody Molecular Drug Customer
12 World Forecast Review for Bispecific Antibody Molecular Drug by Geographic Region
12.1 Global Bispecific Antibody Molecular Drug Market Size Forecast by Region
12.1.1 Global Bispecific Antibody Molecular Drug Forecast by Region (2023-2028)
12.1.2 Global Bispecific Antibody Molecular Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bispecific Antibody Molecular Drug Forecast by Type
12.7 Global Bispecific Antibody Molecular Drug Forecast by Application
13 Key Players Analysis
13.1 MacroGenics
13.1.1 MacroGenics Company Information
13.1.2 MacroGenics Bispecific Antibody Molecular Drug Product Offered
13.1.3 MacroGenics Bispecific Antibody Molecular Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 MacroGenics Main Business Overview
13.1.5 MacroGenics Latest Developments
13.2 Xencor
13.2.1 Xencor Company Information
13.2.2 Xencor Bispecific Antibody Molecular Drug Product Offered
13.2.3 Xencor Bispecific Antibody Molecular Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Xencor Main Business Overview
13.2.5 Xencor Latest Developments
13.3 Medimmune
13.3.1 Medimmune Company Information
13.3.2 Medimmune Bispecific Antibody Molecular Drug Product Offered
13.3.3 Medimmune Bispecific Antibody Molecular Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Medimmune Main Business Overview
13.3.5 Medimmune Latest Developments
13.4 Merrimsck
13.4.1 Merrimsck Company Information
13.4.2 Merrimsck Bispecific Antibody Molecular Drug Product Offered
13.4.3 Merrimsck Bispecific Antibody Molecular Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Merrimsck Main Business Overview
13.4.5 Merrimsck Latest Developments
13.5 Merus NV
13.5.1 Merus NV Company Information
13.5.2 Merus NV Bispecific Antibody Molecular Drug Product Offered
13.5.3 Merus NV Bispecific Antibody Molecular Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Merus NV Main Business Overview
13.5.5 Merus NV Latest Developments
13.6 Genentech
13.6.1 Genentech Company Information
13.6.2 Genentech Bispecific Antibody Molecular Drug Product Offered
13.6.3 Genentech Bispecific Antibody Molecular Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Genentech Main Business Overview
13.6.5 Genentech Latest Developments
13.7 Zhongshan Kangfang Biology Medicine
13.7.1 Zhongshan Kangfang Biology Medicine Company Information
13.7.2 Zhongshan Kangfang Biology Medicine Bispecific Antibody Molecular Drug Product Offered
13.7.3 Zhongshan Kangfang Biology Medicine Bispecific Antibody Molecular Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Zhongshan Kangfang Biology Medicine Main Business Overview
13.7.5 Zhongshan Kangfang Biology Medicine Latest Developments
13.8 Sichuan Baili Pharmaceutical
13.8.1 Sichuan Baili Pharmaceutical Company Information
13.8.2 Sichuan Baili Pharmaceutical Bispecific Antibody Molecular Drug Product Offered
13.8.3 Sichuan Baili Pharmaceutical Bispecific Antibody Molecular Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sichuan Baili Pharmaceutical Main Business Overview
13.8.5 Sichuan Baili Pharmaceutical Latest Developments
13.9 Alphamab Oncology
13.9.1 Alphamab Oncology Company Information
13.9.2 Alphamab Oncology Bispecific Antibody Molecular Drug Product Offered
13.9.3 Alphamab Oncology Bispecific Antibody Molecular Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Alphamab Oncology Main Business Overview
13.9.5 Alphamab Oncology Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Bispecific Antibody Molecular Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Bispecific Antibody Molecular Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of EGFR×HER3 Target
Table 4. Major Players of PD-1×CTLA-4 Target
Table 5. Major Players of HER2×HER3 Target
Table 6. Global Bispecific Antibody Molecular Drug Sales by Type (2017-2022) & (K Units)
Table 7. Global Bispecific Antibody Molecular Drug Sales Market Share by Type (2017-2022)
Table 8. Global Bispecific Antibody Molecular Drug Revenue by Type (2017-2022) & ($ million)
Table 9. Global Bispecific Antibody Molecular Drug Revenue Market Share by Type (2017-2022)
Table 10. Global Bispecific Antibody Molecular Drug Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Bispecific Antibody Molecular Drug Sales by Application (2017-2022) & (K Units)
Table 12. Global Bispecific Antibody Molecular Drug Sales Market Share by Application (2017-2022)
Table 13. Global Bispecific Antibody Molecular Drug Revenue by Application (2017-2022)
Table 14. Global Bispecific Antibody Molecular Drug Revenue Market Share by Application (2017-2022)
Table 15. Global Bispecific Antibody Molecular Drug Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Bispecific Antibody Molecular Drug Sales by Company (2020-2022) & (K Units)
Table 17. Global Bispecific Antibody Molecular Drug Sales Market Share by Company (2020-2022)
Table 18. Global Bispecific Antibody Molecular Drug Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Bispecific Antibody Molecular Drug Revenue Market Share by Company (2020-2022)
Table 20. Global Bispecific Antibody Molecular Drug Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Bispecific Antibody Molecular Drug Producing Area Distribution and Sales Area
Table 22. Players Bispecific Antibody Molecular Drug Products Offered
Table 23. Bispecific Antibody Molecular Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Bispecific Antibody Molecular Drug Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Bispecific Antibody Molecular Drug Sales Market Share Geographic Region (2017-2022)
Table 28. Global Bispecific Antibody Molecular Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Bispecific Antibody Molecular Drug Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Bispecific Antibody Molecular Drug Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Bispecific Antibody Molecular Drug Sales Market Share by Country/Region (2017-2022)
Table 32. Global Bispecific Antibody Molecular Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Bispecific Antibody Molecular Drug Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Bispecific Antibody Molecular Drug Sales by Country (2017-2022) & (K Units)
Table 35. Americas Bispecific Antibody Molecular Drug Sales Market Share by Country (2017-2022)
Table 36. Americas Bispecific Antibody Molecular Drug Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Bispecific Antibody Molecular Drug Revenue Market Share by Country (2017-2022)
Table 38. Americas Bispecific Antibody Molecular Drug Sales by Type (2017-2022) & (K Units)
Table 39. Americas Bispecific Antibody Molecular Drug Sales Market Share by Type (2017-2022)
Table 40. Americas Bispecific Antibody Molecular Drug Sales by Application (2017-2022) & (K Units)
Table 41. Americas Bispecific Antibody Molecular Drug Sales Market Share by Application (2017-2022)
Table 42. APAC Bispecific Antibody Molecular Drug Sales by Region (2017-2022) & (K Units)
Table 43. APAC Bispecific Antibody Molecular Drug Sales Market Share by Region (2017-2022)
Table 44. APAC Bispecific Antibody Molecular Drug Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Bispecific Antibody Molecular Drug Revenue Market Share by Region (2017-2022)
Table 46. APAC Bispecific Antibody Molecular Drug Sales by Type (2017-2022) & (K Units)
Table 47. APAC Bispecific Antibody Molecular Drug Sales Market Share by Type (2017-2022)
Table 48. APAC Bispecific Antibody Molecular Drug Sales by Application (2017-2022) & (K Units)
Table 49. APAC Bispecific Antibody Molecular Drug Sales Market Share by Application (2017-2022)
Table 50. Europe Bispecific Antibody Molecular Drug Sales by Country (2017-2022) & (K Units)
Table 51. Europe Bispecific Antibody Molecular Drug Sales Market Share by Country (2017-2022)
Table 52. Europe Bispecific Antibody Molecular Drug Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Bispecific Antibody Molecular Drug Revenue Market Share by Country (2017-2022)
Table 54. Europe Bispecific Antibody Molecular Drug Sales by Type (2017-2022) & (K Units)
Table 55. Europe Bispecific Antibody Molecular Drug Sales Market Share by Type (2017-2022)
Table 56. Europe Bispecific Antibody Molecular Drug Sales by Application (2017-2022) & (K Units)
Table 57. Europe Bispecific Antibody Molecular Drug Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Bispecific Antibody Molecular Drug Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Bispecific Antibody Molecular Drug Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Bispecific Antibody Molecular Drug Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Bispecific Antibody Molecular Drug Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Bispecific Antibody Molecular Drug Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Bispecific Antibody Molecular Drug Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Bispecific Antibody Molecular Drug Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Bispecific Antibody Molecular Drug Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Bispecific Antibody Molecular Drug
Table 67. Key Market Challenges & Risks of Bispecific Antibody Molecular Drug
Table 68. Key Industry Trends of Bispecific Antibody Molecular Drug
Table 69. Bispecific Antibody Molecular Drug Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Bispecific Antibody Molecular Drug Distributors List
Table 72. Bispecific Antibody Molecular Drug Customer List
Table 73. Global Bispecific Antibody Molecular Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Bispecific Antibody Molecular Drug Sales Market Forecast by Region
Table 75. Global Bispecific Antibody Molecular Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Bispecific Antibody Molecular Drug Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Bispecific Antibody Molecular Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Bispecific Antibody Molecular Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Bispecific Antibody Molecular Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Bispecific Antibody Molecular Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Bispecific Antibody Molecular Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Bispecific Antibody Molecular Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Bispecific Antibody Molecular Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Bispecific Antibody Molecular Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Bispecific Antibody Molecular Drug Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Bispecific Antibody Molecular Drug Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Bispecific Antibody Molecular Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Bispecific Antibody Molecular Drug Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Bispecific Antibody Molecular Drug Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Bispecific Antibody Molecular Drug Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Bispecific Antibody Molecular Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Bispecific Antibody Molecular Drug Revenue Market Share Forecast by Application (2023-2028)
Table 93. MacroGenics Basic Information, Bispecific Antibody Molecular Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. MacroGenics Bispecific Antibody Molecular Drug Product Offered
Table 95. MacroGenics Bispecific Antibody Molecular Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. MacroGenics Main Business
Table 97. MacroGenics Latest Developments
Table 98. Xencor Basic Information, Bispecific Antibody Molecular Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Xencor Bispecific Antibody Molecular Drug Product Offered
Table 100. Xencor Bispecific Antibody Molecular Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Xencor Main Business
Table 102. Xencor Latest Developments
Table 103. Medimmune Basic Information, Bispecific Antibody Molecular Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Medimmune Bispecific Antibody Molecular Drug Product Offered
Table 105. Medimmune Bispecific Antibody Molecular Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Medimmune Main Business
Table 107. Medimmune Latest Developments
Table 108. Merrimsck Basic Information, Bispecific Antibody Molecular Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Merrimsck Bispecific Antibody Molecular Drug Product Offered
Table 110. Merrimsck Bispecific Antibody Molecular Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Merrimsck Main Business
Table 112. Merrimsck Latest Developments
Table 113. Merus NV Basic Information, Bispecific Antibody Molecular Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Merus NV Bispecific Antibody Molecular Drug Product Offered
Table 115. Merus NV Bispecific Antibody Molecular Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Merus NV Main Business
Table 117. Merus NV Latest Developments
Table 118. Genentech Basic Information, Bispecific Antibody Molecular Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. Genentech Bispecific Antibody Molecular Drug Product Offered
Table 120. Genentech Bispecific Antibody Molecular Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Genentech Main Business
Table 122. Genentech Latest Developments
Table 123. Zhongshan Kangfang Biology Medicine Basic Information, Bispecific Antibody Molecular Drug Manufacturing Base, Sales Area and Its Competitors
Table 124. Zhongshan Kangfang Biology Medicine Bispecific Antibody Molecular Drug Product Offered
Table 125. Zhongshan Kangfang Biology Medicine Bispecific Antibody Molecular Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Zhongshan Kangfang Biology Medicine Main Business
Table 127. Zhongshan Kangfang Biology Medicine Latest Developments
Table 128. Sichuan Baili Pharmaceutical Basic Information, Bispecific Antibody Molecular Drug Manufacturing Base, Sales Area and Its Competitors
Table 129. Sichuan Baili Pharmaceutical Bispecific Antibody Molecular Drug Product Offered
Table 130. Sichuan Baili Pharmaceutical Bispecific Antibody Molecular Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Sichuan Baili Pharmaceutical Main Business
Table 132. Sichuan Baili Pharmaceutical Latest Developments
Table 133. Alphamab Oncology Basic Information, Bispecific Antibody Molecular Drug Manufacturing Base, Sales Area and Its Competitors
Table 134. Alphamab Oncology Bispecific Antibody Molecular Drug Product Offered
Table 135. Alphamab Oncology Bispecific Antibody Molecular Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Alphamab Oncology Main Business
Table 137. Alphamab Oncology Latest Developments
List of Figures
Figure 1. Picture of Bispecific Antibody Molecular Drug
Figure 2. Bispecific Antibody Molecular Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bispecific Antibody Molecular Drug Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Bispecific Antibody Molecular Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Bispecific Antibody Molecular Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of EGFR×HER3 Target
Figure 10. Product Picture of PD-1×CTLA-4 Target
Figure 11. Product Picture of HER2×HER3 Target
Figure 12. Global Bispecific Antibody Molecular Drug Sales Market Share by Type in 2021
Figure 13. Global Bispecific Antibody Molecular Drug Revenue Market Share by Type (2017-2022)
Figure 14. Bispecific Antibody Molecular Drug Consumed in Pancreatic Cancer
Figure 15. Global Bispecific Antibody Molecular Drug Market: Pancreatic Cancer (2017-2022) & (K Units)
Figure 16. Bispecific Antibody Molecular Drug Consumed in Breast Cancer
Figure 17. Global Bispecific Antibody Molecular Drug Market: Breast Cancer (2017-2022) & (K Units)
Figure 18. Bispecific Antibody Molecular Drug Consumed in Colorectal Cancer
Figure 19. Global Bispecific Antibody Molecular Drug Market: Colorectal Cancer (2017-2022) & (K Units)
Figure 20. Bispecific Antibody Molecular Drug Consumed in Non-Small Cell Lung Cancer
Figure 21. Global Bispecific Antibody Molecular Drug Market: Non-Small Cell Lung Cancer (2017-2022) & (K Units)
Figure 22. Bispecific Antibody Molecular Drug Consumed in Solid Tumor
Figure 23. Global Bispecific Antibody Molecular Drug Market: Solid Tumor (2017-2022) & (K Units)
Figure 24. Bispecific Antibody Molecular Drug Consumed in Others
Figure 25. Global Bispecific Antibody Molecular Drug Market: Others (2017-2022) & (K Units)
Figure 26. Global Bispecific Antibody Molecular Drug Sales Market Share by Application (2017-2022)
Figure 27. Global Bispecific Antibody Molecular Drug Revenue Market Share by Application in 2021
Figure 28. Bispecific Antibody Molecular Drug Revenue Market by Company in 2021 ($ Million)
Figure 29. Global Bispecific Antibody Molecular Drug Revenue Market Share by Company in 2021
Figure 30. Global Bispecific Antibody Molecular Drug Sales Market Share by Geographic Region (2017-2022)
Figure 31. Global Bispecific Antibody Molecular Drug Revenue Market Share by Geographic Region in 2021
Figure 32. Global Bispecific Antibody Molecular Drug Sales Market Share by Region (2017-2022)
Figure 33. Global Bispecific Antibody Molecular Drug Revenue Market Share by Country/Region in 2021
Figure 34. Americas Bispecific Antibody Molecular Drug Sales 2017-2022 (K Units)
Figure 35. Americas Bispecific Antibody Molecular Drug Revenue 2017-2022 ($ Millions)
Figure 36. APAC Bispecific Antibody Molecular Drug Sales 2017-2022 (K Units)
Figure 37. APAC Bispecific Antibody Molecular Drug Revenue 2017-2022 ($ Millions)
Figure 38. Europe Bispecific Antibody Molecular Drug Sales 2017-2022 (K Units)
Figure 39. Europe Bispecific Antibody Molecular Drug Revenue 2017-2022 ($ Millions)
Figure 40. Middle East & Africa Bispecific Antibody Molecular Drug Sales 2017-2022 (K Units)
Figure 41. Middle East & Africa Bispecific Antibody Molecular Drug Revenue 2017-2022 ($ Millions)
Figure 42. Americas Bispecific Antibody Molecular Drug Sales Market Share by Country in 2021
Figure 43. Americas Bispecific Antibody Molecular Drug Revenue Market Share by Country in 2021
Figure 44. United States Bispecific Antibody Molecular Drug Revenue Growth 2017-2022 ($ Millions)
Figure 45. Canada Bispecific Antibody Molecular Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. Mexico Bispecific Antibody Molecular Drug Revenue Growth 2017-2022 ($ Millions)
Figure 47. Brazil Bispecific Antibody Molecular Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. APAC Bispecific Antibody Molecular Drug Sales Market Share by Region in 2021
Figure 49. APAC Bispecific Antibody Molecular Drug Revenue Market Share by Regions in 2021
Figure 50. China Bispecific Antibody Molecular Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. Japan Bispecific Antibody Molecular Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. South Korea Bispecific Antibody Molecular Drug Revenue Growth 2017-2022 ($ Millions)
Figure 53. Southeast Asia Bispecific Antibody Molecular Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. India Bispecific Antibody Molecular Drug Revenue Growth 2017-2022 ($ Millions)
Figure 55. Australia Bispecific Antibody Molecular Drug Revenue Growth 2017-2022 ($ Millions)
Figure 56. Europe Bispecific Antibody Molecular Drug Sales Market Share by Country in 2021
Figure 57. Europe Bispecific Antibody Molecular Drug Revenue Market Share by Country in 2021
Figure 58. Germany Bispecific Antibody Molecular Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. France Bispecific Antibody Molecular Drug Revenue Growth 2017-2022 ($ Millions)
Figure 60. UK Bispecific Antibody Molecular Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. Italy Bispecific Antibody Molecular Drug Revenue Growth 2017-2022 ($ Millions)
Figure 62. Russia Bispecific Antibody Molecular Drug Revenue Growth 2017-2022 ($ Millions)
Figure 63. Middle East & Africa Bispecific Antibody Molecular Drug Sales Market Share by Country in 2021
Figure 64. Middle East & Africa Bispecific Antibody Molecular Drug Revenue Market Share by Country in 2021
Figure 65. Egypt Bispecific Antibody Molecular Drug Revenue Growth 2017-2022 ($ Millions)
Figure 66. South Africa Bispecific Antibody Molecular Drug Revenue Growth 2017-2022 ($ Millions)
Figure 67. Israel Bispecific Antibody Molecular Drug Revenue Growth 2017-2022 ($ Millions)
Figure 68. Turkey Bispecific Antibody Molecular Drug Revenue Growth 2017-2022 ($ Millions)
Figure 69. GCC Country Bispecific Antibody Molecular Drug Revenue Growth 2017-2022 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Bispecific Antibody Molecular Drug in 2021
Figure 71. Manufacturing Process Analysis of Bispecific Antibody Molecular Drug
Figure 72. Industry Chain Structure of Bispecific Antibody Molecular Drug
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets